Dabur India (DABUR) Q4 99/00 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 99/00 earnings summary
23 Oct, 2026Executive summary
FY99/00 sales grew 13.5% to Rs 1,042.59 crore, outperforming an FMCG market where most peers posted single-digit growth.
Profit after tax was Rs 77.43 crore, including a Rs 9 crore write-off of bad debts tied to the earlier collection system.
Financial highlights
Turnover including other income rose to Rs 1,076.78 crore from Rs 932.19 crore; profit before tax increased to Rs 81.29 crore from Rs 51.60 crore.
Net profit was Rs 77.43 crore versus Rs 50.10 crore in FY98/99; EPS increased to Rs 27.15 from Rs 17.58.
Other income included Rs 21.04 crore profit on investment sales; the income statement also recorded a Rs 9 crore bad-debt write-off.
Outlook and guidance
The Rs 2,000 crore turnover target, initially set for FY02/03, was expected in FY03/04 as FMCG growth slowed; continued outperformance of the sector was anticipated.
Focus on natural, herbal healthcare and personal care, new product launches, and efficiency gains; profitability improvement targeted over the next 3–4 years.
Latest events from Dabur India
- Q2 revenue reached ₹3,563.07 crore; a ₹3.50 interim dividend was declared.DABUR
Q2 26/27 - Revenue and PAT advanced as exports and manufacturing capacity expanded.DABUR
Q4 96/97 - Core-brand focus and proposed portfolio exits underpin a Rs 2,000 crore FY03 target.DABUR
Q4 97/98 - Sales grew 12.7% as restructuring sharpened focus on core growth businesses.DABUR
Q4 98/99 - Flat sales, lower reported profit, and investment in global oncology growth.DABUR
Q4 01/02 - Sales outpaced a slow FMCG market as adjusted profit rose 39.2% and debt fell 32%.DABUR
Q4 00/01 - Profit rose 32.1% as efficiencies offset weak FMCG demand and restructuring advanced.DABUR
Q4 02/03 - Revenue rose 9.5% and PAT 40.6% despite weak FMCG demand.DABUR
Q4 03/04 - FY05 delivered higher growth and margins; Balsara broadened the portfolio as input-cost risks persisted.DABUR
Q4 04/05